Loustaud-Ratti V - Search Results

1

Hepatitis B Virus Blocks the CRE/CREB Complex and Prevents TLR9 Transcription and Function in Human B Cells.

Tout I, Gomes M, Ainouze M, Marotel M, Pecoul T, Durantel D, Vaccarella S, Dubois B, Loustaud-Ratti V, Walzer T, Alain S, Chemin I, Hasan U. Tout I, et al. J Immunol. 2018 Oct 15;201(8):2331-2344. doi: 10.4049/jimmunol.1701726. Epub 2018 Sep 5. J Immunol. 2018. PMID: 30185518

2

Double hepatitis B virus infection in a patient with HIV/hepatitis C virus coinfection and 'anti-HBc alone' as serological pattern.

Wagner AA, Loustaud-Ratti V, Chemin I, Weinbreck P, Denis F, Alain S. Wagner AA, et al. Eur J Clin Microbiol Infect Dis. 2005 Sep;24(9):623-7. doi: 10.1007/s10096-005-0010-1. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16193323

3

Distribution of total DNA and cccDNA in serum and PBMCs may reflect the HBV immune status in HBsAg+ and HBsAg- patients coinfected or not with HIV or HCV.

Loustaud-Ratti V, Wagner A, Carrier P, Marczuk V, Chemin I, Lunel F, Fouchard-Hubert I, Ahmed SS, Abergel A, Rousseau A, Lefebvre A, Debette-Gratien M, Denis F, Alain S. Loustaud-Ratti V, et al. Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):373-83. doi: 10.1016/j.clinre.2012.11.002. Epub 2013 Mar 9. Clin Res Hepatol Gastroenterol. 2013. PMID: 23477988

4

Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.

Loustaud-Ratti V, Alain S, Rousseau A, Hubert IF, Sauvage FL, Marquet P, Denis F, Lunel F, Calès P, Lefebvre A, Fauchais AL, Liozon E, Vidal E. Loustaud-Ratti V, et al. Hepatology. 2008 May;47(5):1453-61. doi: 10.1002/hep.22217. Hepatology. 2008. PMID: 18435468 Free article.

5

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.

Ducancelle A, Pivert A, Bertrais S, Boursier J, Balan V, Veillon P, le Guillou-Guillemette H, Thibault V, Castelain S, Roquebert B, Coste-Burel M, Mackiewicz V, Schvoerer E, Larrat S, Maylin S, Alain S, Loustaud-Ratti V, Gordien E, Gozlan J, Brodard V, Chevaliez S, Calès P, Lunel-Fabiani F. Ducancelle A, et al. J Gastroenterol Hepatol. 2016 Oct;31(10):1750-1756. doi: 10.1111/jgh.13338. J Gastroenterol Hepatol. 2016. PMID: 26992056

6

Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients.

Mazet-Wagner AA, Baclet MC, Loustaud-Ratti V, Denis F, Alain S. Mazet-Wagner AA, et al. J Virol Methods. 2006 Dec;138(1-2):70-9. doi: 10.1016/j.jviromet.2006.07.019. Epub 2006 Sep 7. J Virol Methods. 2006. PMID: 16962180

7

Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection.

Loustaud-Ratti V, Liozon E, Karaaslan H, Alain S, Paraf F, Le Meur Y, Denis F, Vidal E. Loustaud-Ratti V, et al. Am J Med. 2002 Oct 15;113(6):516-9. doi: 10.1016/s0002-9343(02)01257-3. Am J Med. 2002. PMID: 12427502 No abstract available.

8

[Evolution of Sjögren syndrome associated with hepatitis C virus when chronic hepatitis C is treated by interferon or the association of interferon and ribavirin].

Doffoël-Hantz V, Loustaud-Ratti V, Ramos-Casals M, Alain S, Bezanahary H, Liozon E, Fauchais AL, Vidal E. Doffoël-Hantz V, et al. Rev Med Interne. 2005 Feb;26(2):88-94. doi: 10.1016/j.revmed.2004.10.020. Rev Med Interne. 2005. PMID: 15710254 French.

9

Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.

Loustaud-Ratti V, Maynard M, Thevenon S, Pradat P, Rousseau A, Alain S, Deny P, Gagnieu MC, Tran A, Dao T, Silvain C, Lunel-Fabiani F, Picard N, Zublena I, Marquet P, Trepo C; RIBAJUSTE Group. Loustaud-Ratti V, et al. Ther Drug Monit. 2016 Dec;38(6):684-692. doi: 10.1097/FTD.0000000000000332. Ther Drug Monit. 2016. PMID: 27559840 Clinical Trial.

10

Ribavirin in chronic hepatitis C: past and future.

Loustaud-Ratti V, Rousseau A, Marquet P, Denis F, Alain S. Loustaud-Ratti V, et al. Expert Rev Anti Infect Ther. 2009 Apr;7(3):249-53. doi: 10.1586/eri.09.5. Expert Rev Anti Infect Ther. 2009. PMID: 19344238 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page